santen Pages on BioPortfolio:

BioPortfolio - santen pharma uk
santen pharma uk - BioPortfolio. ... Santen Incorporated, a wholly owned subsidiary of Santen Pharmaceutical Co., Ltd., ... Recent Search Terms used to
find ...
http://www.bioportfolio.com/search/santen_pharma_uk.html...

BioPortfolio - santen incorporated
santen incorporated - BioPortfolio. ... Santen Incorporated - Entry on Bioportfolio's Biocorporate Database. ...
http://www.bioportfolio.com/search/santen_incorporated.html...

BioPortfolio - santen vistakon
santen vistakon - BioPortfolio. ... BioPortfolio - santen vistakon In early 2004 , Santen entered into a partnership agreement with VISTAKON® Pharmaceuticals ...
http://www.bioportfolio.com/search/santen_vistakon.html...

Results from other life science and pharmaceutical sites:

BioSpace - Santen, Inc. News, Search Jobs, Events
Santen, Inc. Announces Preliminary Results Of Overseas Clinical Trials Of Two Glaucoma Drug Candidates; DE-092 Efficacy Insufficient 2/14/2006 2:51:27 PM ...
http://www.biospace.com/company_profile.aspx?CompanyId=4159...

BioSpace - Santen Pharmaceutical News, Search Jobs, Events
Santen Pharmaceutical and MacuSight, Inc. Announce Collaboration and License Agreement for Sirolimus in Ocular Diseases and Conditions; MacuSight to Receive
...
http://www.biospace.com/company_profile.aspx?CompanyId=37904...

C:\LORI\SANTEN\21199 S3 AP 6-3-02 phys sample .DOC
Santen Oy, P.O. Box 33, FIN-33721 Tampere, Finland. Marketed by:. Santen Inc. Napa, CA 94558, ... Santen Inc. Napa, CA 94558 USA. Licensed from Daiichi ...
http://www.fda.gov/Cder/foi/label/2002/21199s003lbl.pdf...

Santen Pharmaceutical and MacuSight, Inc. Announce Collaboration ...
2 Jun 2008 ... Under terms of the agreement, Santen receives rights to develop and commercialize sirolimus for ocular diseases and conditions in Japan and ...
http://www.biospace.com/news_story.aspx?NewsEntityId=98478...

NDA 21-199/S-002 Santen Incorporated Attention: Nancy Yee ...
Santen Incorporated. Attention: Nancy Yee. Regulatory Affairs Specialist II. 555 Gateway Drive. Napa, CA 94558. Dear Ms. Yee: ...
http://www.fda.gov/cder/foi/appletter/2002/21199s2ltr.pdf...

C:\LORI\SANTEN\21571 AP ltr 2-18-04.doc
Santen Oy, P.O. Box 33, FIN-33721 Tampere, Finland. Marketed by:. Vistakon Pharmaceuticals, LLC. Jacksonville, FL 32256, U.S.A.. Licensed from: ...
http://www.fda.gov/cder/foi/label/2004/21571_iquix_lbl.pdf...

Diquafosol tetrasodium Inspire/Allergan/Santen Jorge Fischbarg
Inspire, in collaboration with Allergan and Santen, is developing ..... In January 1999, Santen and Inspire entered into a strategic partnership to develop
...
http://www.biomedcentral.com/content/pdf/cd-513733.pdf...

DailyMed: About DailyMed
Revised: 08/2007Santen Inc. Visit The National Library of Medicine Copyright, Privacy, Accessibility · U.S. National Library of Medicine, 8600 Rockville ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=5139...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.